Coronavirus: need for a therapeutic approach

This publication has 13 references indexed in Scilit:

• MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
  Journal of General Virology, 2013
• Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
  mBio, 2013
• Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections
  New England Journal of Medicine, 2013
• Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
  The Lancet, 2013
• Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
  Scientific Reports, 2013
• Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
  Journal of Infection, 2013
• The newly emerged SARS-Like coronavirus HCoV-EMC also has an “Achilles’ heel”: current effective inhibitor targeting a 3C-like protease
  Protein & Cell, 2013
• Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
  New England Journal of Medicine, 2012
• SARS: Systematic Review of Treatment Effects
  PLoS Medicine, 2006
• Severe acute respiratory syndrome
  Nature Medicine, 2004